Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
MYCARE START: FEASIBILITY STUDY OF A NEW MEDICINES SERVICE IN SWISS COMMUNITY PHARMACIES
- At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
- Type: Presentation
- By: BESANçON, Luc (pharmaSuisse, Switzerland)
- Co-author(s): Isabelle Krummenacher: pharmaSuisse, Bern-Liebefeld, Switzerland
Samuel Alleman: pharmaSuisse, Bern-Liebefeld, Switzerland
Daniela Stebler: pharmaSuisse, Bern-Liebefeld, Switzerland
Luc Besançon: pharmaSuisse, Bern-Liebefeld, Switzerland
Martine Ruggli: pharmaSuisse, Bern-Liebefeld, Switzerland
Fabian Vaucher: pharmaSuisse, Bern-Liebefeld, Switzerland - Abstract:
Background
The Swiss Association of Pharmacists (pharmaSuisse) developed a new service called "myCare Start" inspired by the New Medicines Service (UK) and other European models. It aims to promote adherence at the start of a new chronic therapy. It offers patient-centered and outcome-oriented support through 2 consultations within the first 6
.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 4 October 2019